KDM5B Polyclonal Antibody, PE Conjugated
- Size: 100ul
- Application: FCM
- Reactivity: Human, Rat
- Predicted Reactivity: Mouse, Dog, Cow, Pig, Horse, Chicken, Guinea Pig
-
Datasheet Tech Support
PRODUCT DETAILS
SPECIFICATIONS |
|
---|---|
PRODUCT NAME |
KDM5B Polyclonal Antibody, PE Conjugated |
CONJUGATION |
PE |
HOST |
Rabbit |
SOURCE |
KLH conjugated synthetic peptide derived from human KDM5B/Jarid1B |
IMMUNOGEN RANGE |
65-165/1544 |
CLONALITY |
Polyclonal |
ISOTYPE |
IgG |
CONCENTRATION |
1ug/ul |
PURIFICATION |
Purified by Protein A. |
STORAGE BUFFER |
Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. |
STORAGE CONDITION |
Store at 4°C for 12 months. |
TARGET |
|
---|---|
GENE ID |
|
SUBCELLULAR LOCATION |
Nucleus |
SYNONYMS |
CT31; PLU1; PUT1; PLU-1; JARID1B; PPP1R98; RBBP2H1A; Lysine-specific demethylase 5B; Cancer/testis antigen 31; Histone demethylase JARID1B; Jumonji/ARID domain-containing protein 1B; Retinoblastoma-binding protein 2 homolog 1; RBP2-H1; KDM5B; RBBP2H1 |
BACKGROUND |
Histone demethylase that demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code. Does not demethylate histone H3 'Lys-9' or H3 'Lys-27'. Demethylates trimethylated, dimethylated and monomethylated H3 'Lys-4'. Acts as a transcriptional corepressor for FOXG1B and PAX9. Favors the proliferation of breast cancer cells by repressing tumor suppressor genes such as BRCA1 and HOXA5. In contrast, may act as a tumor suppressor for melanoma. Represses the CLOCK-ARNTL/BMAL1 heterodimer-mediated transcriptional activation of the core clock component PER2 (By similarity). |
APPLICATION DILUTION |
FCM(1:20-100) |